Beiersdorf stock holds after 2025 sales and profit update

Beiersdorf stock is anchored by its 2025 results, with sales of EUR 9.9 billion and an EBIT margin of 13.8%, while the dividend was raised 12.1% to EUR 1.00 per share for 2025. The company also said its Consumer business and Derma portfolio remained central to growth in the latest investor overview.

Sales near EUR 10 billion

Beiersdorf reported 2025 sales of EUR 9.9 billion, compared with EUR 9.5 billion in the prior year, which points to a clear year-on-year increase in the top line. EBIT margin reached 13.8% in 2025, against 13.7% in 2024, showing only a narrow improvement in profitability.

The dividend move adds a second concrete marker for shareholders. Beiersdorf lifted the 2025 payout to EUR 1.00 per share from EUR 0.89 in 2024, an increase of 12.1%.

Margin stays in focus

For investors, the key detail is that Beiersdorf still combined a higher sales base with only modest margin expansion in 2025. That mix suggests the company is still relying on volume and brand strength rather than a large step-change in profitability.

The latest investor overview also keeps attention on the company’s capital allocation, because the dividend increase came alongside sales growth and stable operating profitability. That combination matters more than any single line in the report.

Consumer and Derma

Beiersdorf has continued to position Consumer and Derma as the core of its portfolio, with skincare brands carrying much of the group story. The investor overview is the most relevant reference point here, because it links the reporting numbers with the product mix that drives them.

That matters for the market reading of Beiersdorf stock: a consumer-goods group with EUR 9.9 billion in sales and a 13.8% EBIT margin is judged less on short bursts of growth than on repeatability.

Stock level

Beiersdorf shares are quoted in Frankfurt on Xetra under the ticker XETRA: BEI as the standard trading venue reference for the German listing. The stock can be assessed against the 2025 financial base of EUR 9.9 billion in sales, EUR 1.00 dividend per share and a 13.8% EBIT margin.